|
HS Code |
298208 |
| Productname | 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester |
| Casnumber | 87120-72-7 |
| Molecularformula | C14H11BrO2 |
| Molecularweight | 291.14 |
| Appearance | White to off-white solid |
| Meltingpoint | 109-113°C |
| Purity | Typically >98% |
| Solubility | Insoluble in water, soluble in organic solvents |
| Smiles | COC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)Br |
| Inchi | InChI=1S/C14H11BrO2/c1-17-14(16)11-7-9-13(10-8-11)12-5-3-2-4-6-12(15)10-8-11/h2-9H,1H3 |
As an accredited 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Specialty chemicals often steer the direction of progress across pharmaceuticals, materials science, and organic electronics. 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester stands out in this landscape, building on years of research with biphenyl scaffolds and bridging the gap between raw material and refined end product. Its structure offers a versatile platform that can adapt to a surprising number of modifications, helping chemists and engineers create better drugs, smarter polymers, and more reliable display materials.
A close inspection reveals what gives this compound its edge. The presence of a bromine atom at the 4' position on the biphenyl core dramatically opens up options for cross-coupling reactions, such as Suzuki or Heck-type transformations. The methyl ester group on the carboxylic acid tail allows for straightforward hydrolysis or amidation, so labs can convert this ester to a suite of derivatives. The molecular formula, C14H11BrO2, strikes a balance between reactivity and manageability—there’s enough molecular heft for thermal stability, but not enough to slow down the reaction kinetics prized in medicinal chemistry scale-ups.
On the bench, this solid typically presents as a white or off-white powder. Purity usually checks out north of 98%, measured against strict industry standards. Given its relatively high melting point, storage is uncomplicated—no fancy equipment or inert atmospheres required under ordinary lab setups. I’ve worked in both university and startup settings with derivatives much less forgiving. Nothing derails a workflow like a temperature-sensitive intermediate that degrades if left out; this compound sidesteps those headaches. Packaged in airtight, light-resistant containers, you’ll find shelf life extends well beyond the immediate project timeline, letting researchers plan their syntheses without constant reordering.
Others might wonder if it’s just another building block in an overcrowded catalog. That’s not the case. Unlike unsubstituted biphenyl methyl esters, the 4'-bromo version responds reliably to palladium-catalyzed couplings—a critical feature for anyone constructing complex molecular architectures. Once, in my own synthesis of a custom OLED precursor, a similar aryl bromide intermediate saved hours and precious material compared to an iodide analog, which demanded gentler, slower conditions. That subtle edge becomes massive on production or even multi-gram development scales.
Competition between halogenated biphenyl esters usually comes down to two factors: ease of activation and downstream flexibility. Some labs reach for 4'-iodo- or 4'-chloro-substituted analogs thinking stronger leaving groups make for faster reactions. Reality flips the script. Iodinated biphenyls often inflate costs and tend to decompose under the wrong conditions. Chloro versions ask for higher temperatures, which risk side products and tank the overall yield. The 4'-bromo compound gets it just right—fast enough to suit high-throughput settings, stable enough for routine handling. In a medicinal chemistry context, this difference alone can save several days in an already demanding workflow.
Pharmaceutical researchers see value immediately. Lots of drug candidates start life on a biphenyl backbone. Swapping in different functional groups at key positions tunes everything from metabolic stability to bioavailability. The 4'-bromo group gives project teams a launching pad: introduce a bulky substituent to block an enzyme site, graft in a polar residue to dial solubility, or stitch on a fluorescent tag. During a multi-year stint in drug development, I noticed how quickly libraries based on this motif moved from the synthetic bench to in vitro testing.
Polymer scientists ride a parallel track. The biphenyl unit contributes rigidity and planarity, which strengthens π-π stacking and ultimately improves device performance in OLEDs, photovoltaic cells, or high-performance plastics. With this ester, the methyl group stays put through a lot of standard coupling reactions, yet it can be clipped off by saponification whenever a carboxylate function is needed. When synthesizing a particularly stretch-resistant polyimide, colleagues in my network found this flexibility irreplaceable. Every new material trades on its starting monomer; this ester brings precision to the choices at the crossroads of design and manufacturability.
Many practitioners start their selection process considering cost or shelf life, but the real story unfolds through hands-on trial. Some look at 4-methoxy or 4-fluoro biphenyl esters, drawn in by the promise of unique electronic effects. In practice, those substituents tend to limit follow-up transformations. The bromo group pulls double-duty: activating the ring toward further functionalization and acting as a leaving group in coupling protocols. Since Suzuki couplings under optimized conditions can reach yields above 90%, the value proposition turns obvious. Take any kilogram-scale production—slashing even a single purification step or raising yields by a few points translates into thousands of savings.
I’ve watched production teams wrestle with purity issues caused by trace halogen contamination from 4-chloro analogs. A trace impurity at the wrong site can destroy an otherwise promising device. Brominated esters limit off-target reactivity and simplify quality control, especially under high-throughput screening. Labs working under tight deadlines for new OLED emitters or exploratory sensor arrays routinely opt for this methyl ester because it strikes a compromise between adaptability, performance, and easy characterization by NMR or mass spectrometry.
Speed and selectivity draw a direct route to project completion. Professor colleagues pushing toward next-generation kinase inhibitors or antimicrobial pharmacophores want options from their intermediates. In hands-on synthesis sessions, this compound performs reliably—nucleophilic aromatic substitutions fly through with minimal overreaction, and cross-couplings leave minimal byproducts. This gives both small startups and large R&D outfits more room to maneuver, cutting down on wasted raw material and sluggish purification processes.
Safety and environmental factors add another layer of appeal. Compared to halogenated phenolics or polyhalogenated biphenyls, this bromo ester generally avoids the kinds of persistent organic pollutant concerns driving regulatory headaches. Handling protocols are straightforward, and standard lab hygiene—good ventilation, routine glove use—easily covers the bases. For teams building out sustainable or green chemistry initiatives, steering clear from unnecessary toxic halides without giving up synthetic leverage remains vital.
Research-grade 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester lands on a shelf ready to plug into organic synthesis workflows. Inventory managers appreciate its non-perishable nature; reorder cycles are predictable, and lead times rarely cause bottlenecks. On smaller scales, I’ve handled this compound week in and week out in a graduate lab, weighing, transferring, or dissolving it with low effort. Scale-up in pilot or commercial settings almost mirrors bench procedures, which simplifies training for less experienced personnel.
Documentation for health and safety checks out, with no surprise hazards lurking. In experimental setups involving organometallic catalysts, I often gauge an intermediate’s quality by how many workups or chromatographic steps it takes to get to the next stage. This ester usually sails through purification, eliminating the need for elaborate setups or specialized solvents. From a workflow point of view, that’s gold—especially during crunch time on grant-funded projects, or for companies juggling multiple product candidates in parallel. Robustness and reliability buy peace of mind in an unpredictable research environment.
The evolution of synthetic strategies tracks closely with the kind of intermediates available. Every time an innovation comes along—a new coupling protocol, a novel catalyst, a shortcut that trims steps—the whole field moves forward. This methyl ester forms a pivot point in a range of transformations. Its combination of halogen reactivity and protected acid functionality has led some teams to refer to it as the “skeleton key” for biphenyl manipulations. The presence of the bromo group allows expansion across combinatorial libraries without the cost or instability of heavier halogens, and the methyl ester function makes quick hydrolysis practical, delivering carboxylate products in short order.
Cost-conscious operations benefit in the medium to long term. I’ve worked through budgets where material expenses needed to stretch across multiple quarters, and building synthetic routes around cost-effective reagents made a tangible difference. Minimizing the number of custom steps, maximizing the flexibility with one intermediate, and shaving time off purification saves money, especially on the scale demanded by industrial settings. Production managers see gains not only in labor but also in the downstream cost of waste disposal—less hazardous byproduct, less investment in accident-proofing, fewer disposal headaches for regulatory compliance teams.
Researchers today rarely stand still. The demand for smarter drugs, better-performing electronics, and greener materials keeps the field in motion. By enabling access to an essential biphenyl core, this methyl ester supports a wide variety of cutting-edge research. In my own experience developing enzyme inhibitors, this starting material shortened timelines, freeing up bandwidth to design and optimize actual candidate molecules instead of slogging through repetitive intermediate synthesis. Fast access to couplable, modifiable scaffolds gives small labs a fighting chance against better-funded rivals.
Device manufacturers also depend on the reliability of their raw materials. Whether the goal is a new generation of flexible OLEDs, a transparent conductor for solar cells, or simply a robust starting point for dyes and pigments, the balance of reactivity and stability in this ester eliminates some of the guesswork. Teams aiming to push boundaries appreciate intermediates that minimize production hiccups, keep yields high, and demand fewer purification cycles. These features not only lower production costs but also lower the bar to entry for smaller manufacturers hoping to compete.
Education and training stand front and center in keeping work safe and repeatable. In my time mentoring undergraduates and early-career chemists, robust compounds like this methyl ester became teaching tools—not just building blocks. New learners quickly understood why bromo-derivatives offer a sweet spot between activation energy and decomposition risk. Rather than tiptoe around unstable substances, trainees can focus on mastering technique and troubleshooting real synthesis problems. This kind of lesson lasts longer than a single experiment and raises the standard of practice in every lab equipped to use it.
At a time when reproducibility and quality assurance have never mattered more, intermediates like 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester play an outsize role. Reliable, high-purity substrate supports analytic comparisons, structure confirmation, and process standardization. Researchers can trust that bioactivity or device performance variations reflect meaningful chemistry rather than noise from an unpredictable starting material. This alone elevates the level at which teams can innovate, iterate, and share their findings across both academic and industrial networks.
Sustainability drives new questions for everyone in the chemical supply chain. Less toxic waste, fewer harsh reagents, and materials with well-understood hazard profiles rank among the new gold standards. In projects focused on green chemistry, this bromo ester lets teams lean away from problematic halogenated byproducts. On a mixed-use campus I once consulted for, process engineers highlighted how quick, high-yield conversions from this intermediate slashed both energy use and hazardous material outflows.
Custom synthesis projects require adaptability. The methyl ester acts as a protective group, surviving the sorts of coupling or substitution conditions that would wreck unprotected acids or more labile esters. Teams can uncover routes to previously inaccessible biphenyl derivatives by iterating on this single, well-balanced intermediate. Product designers and process chemists alike can chase better performance without constant reinvention—a rare situation in synthetic chemistry, where one limited reagent or unstable building block too often derails the entire roadmap.
End users don’t care about raw materials for their own sake—they want reliable results at the finish line. The edge that comes from a carefully designed intermediate shows up in a faster-paced research environment, earlier resolution of manufacturing challenges, and the freedom to try new things. It takes years to build up experience with the quirks and strengths of a particular reagent. With a compound like 4'-Bromo[1,1'-Biphenyl]-4-Carboxylic Acid Methyl Ester, that edge becomes tangible—fewer worries about unwanted sidereactions, more confidence that downstream steps will work, and a stronger hand at both the planning and execution table.
My years in synthetic labs, side-by-side with chemists from both industry and academia, made it clear: even small differences in reactivity or manageability can set one intermediate apart from dozens of others. In the case of this methyl ester, the path it opens toward high-value pharmaceuticals, advanced polymers, and emerging electronics makes it more than just a reactant—it's a cornerstone for countless innovative solutions. With well-understood properties, a routine handling profile, and enough track record to inspire real trust, this compound suits the needs of researchers looking to push the boundaries of what’s possible, today and tomorrow.